Related Experiment Videos
Mitochondrial DNA depletion and dGK gene mutations
Leonardo Salviati1, Sabrina Sacconi, Michelangelo Mancuso
1Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Annals of Neurology
|September 3, 2002
Summary
Mutations in the deoxyguanosine kinase (dGK) gene were found in 14% of patients with mitochondrial DNA depletion syndrome. These genetic variations contribute to the disease
Area of Science:
- Genetics
- Molecular Biology
- Pediatric Medicine
Background:
- Mitochondrial DNA depletion syndrome (MDDS) is a group of inherited metabolic disorders.
- MDDS is characterized by reduced mitochondrial DNA copy number, leading to cellular dysfunction.
- The hepatocerebral form of MDDS has a significant impact on liver and neurological function.
Purpose of the Study:
- To determine the frequency of deoxyguanosine kinase (dGK) gene mutations in patients with hepatocerebral MDDS.
- To further define the clinical spectrum associated with dGK mutations.
- To correlate specific dGK genotypes with observed phenotypes.
Main Methods:
- Genetic screening of 21 patients diagnosed with MDDS.
- Mutation analysis of the deoxyguanosine kinase (dGK) gene.
- Clinical data collection and phenotype-genotype correlation.
Main Results:
- Mutations in the dGK gene were identified in 3 out of 21 patients (14%).
- Identified mutations included a homozygous GATT duplication, a homozygous GT deletion, and compound heterozygous missense mutations.
- These mutations resulted in truncated or altered dGK proteins, leading to variable clinical presentations.
- Low mutation frequency suggests dGK is not the sole genetic cause of liver MDDS.
Conclusions:
- dGK mutations are a rare cause of hepatocerebral mitochondrial DNA depletion syndrome.
- The identified mutations lead to diverse clinical phenotypes.
- Liver transplantation may be a viable treatment option for selected patients with dGK-related liver failure.